Twist Bioscience
TWST
Twist Bioscience (TWST) news
Recent news
Bio-pharmaceutical stocks rose in intraday trading, with Biogen up 3.7%, Regeneron gaining 2.3% and Twist Bioscience rising 3.2%.
Bio-pharmaceutical stocks experienced gains during intraday trading on October 12, 2026, with several key names showing positive momentum. Biogen (BIIB) rose by 3.7%, while Regeneron (REGN) added 2.3% and Twist Bioscience (TWST) climbed 3.2%. The sector’s performance reflects ongoing investor…
AInvest Wire · 11h agoTwist Bioscience Corporation: Leerink partners raises target price to $160 from $120
AInvest Wire · Sep 17, 2026Twist Bioscience in pact with Lilly tunelab
AInvest Wire · Sep 16, 2026Twist Bioscience joins Lilly Tunelab to advance antibody drug discovery
AInvest Wire · Sep 16, 2026Twist Bioscience Corporation: UBS initiates coverage with neutral rating and target price $144
AInvest Wire · Sep 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.